サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387369

上咽頭がん市場レポート：2030年までの動向、予測、競合分析

Nasopharyngeal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

上咽頭がん市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

上咽頭がんの動向と予測

世界の上咽頭がん市場は、2024年から2030年にかけてCAGR 3.4％で成長すると予測されます。この市場の主な促進要因は、上咽頭がんの罹患率の増加、がん研究およびイニシアチブのための政府資金の増加です。世界の上咽頭がん市場の将来は、病院・診療所、外来手術センター市場における機会によって有望視されています。

上咽頭がん市場の洞察

Lucintelの予測では、化学療法はがん細胞を死滅させる非常に効果的な治療法と考えられているため、予測期間中に最も高い成長が見込まれています。

この市場では、他の環境では通常利用できない専門的な機器や専門知識を利用する必要性が高まっているため、病院・診療所が最大のセグメントであり続けると思われます。

北米は、がんの罹患率が高く、治療と診断に対する意識が高まっていることから、予測期間中も最大の地域です。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の上咽頭がん市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の上咽頭がん市場動向（2018～2023年）と予測（2024～2030年）
  • 治療別の世界の上咽頭がん市場
    • 化学療法
    • 免疫療法
    • 放射線治療
    • その他
  • 最終用途別の世界の上咽頭がん市場
    • 病院・診療所
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の上咽頭がん市場
  • 北米の上咽頭がん市場
  • 欧州の上咽頭がん市場
  • アジア太平洋の上咽頭がん市場
  • その他地域の上咽頭がん市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 治療別の世界の上咽頭がん市場の成長機会
    • 最終用途別の世界の上咽頭がん市場の成長機会
    • 地域別の世界の上咽頭がん市場の成長機会
  • 世界の上咽頭がん市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の上咽頭がん市場の能力拡大
    • 世界の上咽頭がん市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Biocon
  • Bristol-Myers Squibb Company
  • Cyclacel Pharmaceuticals
  • F. Hoffman-La Roche
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • Theravectys
  • Eli Lilly and Company
目次

Nasopharyngeal Cancer Trends and Forecast

The future of the global nasopharyngeal cancer market looks promising with opportunities in the hospitals and clinic and ambulatory surgery center markets. The global nasopharyngeal cancer market is expected to grow with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are growing incidence of nasopharyngeal cancer and increasing government funding for cancer research and initiatives.

A more than 150-page report is developed to help in your business decisions.

Nasopharyngeal Cancer by Segment

The study includes a forecast for the global nasopharyngeal cancer by therapy, end use, and region.

Nasopharyngeal Cancer Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Others

Nasopharyngeal Cancer Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others

Nasopharyngeal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Nasopharyngeal Cancer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nasopharyngeal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nasopharyngeal cancer companies profiled in this report include-

  • Biocon
  • Bristol-Myers Squibb Company
  • Cyclacel Pharmaceuticals
  • F. Hoffman-La Roche
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • Theravectys
  • Eli Lilly and Company

Nasopharyngeal Cancer Market Insights

Lucintel forecasts that chemotherapy is expected to witness highest growth over the forecast period as it is considered as very effective treatment for killing cancer cells.

Within this market, hospitals and clinics will remain the largest segment due to growing need to access to specialized equipment and expertise that is not typically available in other settings.

North America will remain the largest region over the forecast period due to high prevalence of cancer and growing awareness towards treatment and diagnosis in the region.

Features of the Global Nasopharyngeal Cancer Market

Market Size Estimates: Nasopharyngeal cancer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nasopharyngeal cancer market size by therapy, end use, and region in terms of value ($B).

Regional Analysis: Nasopharyngeal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapies, end uses, and regions for the nasopharyngeal cancer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nasopharyngeal cancer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for nasopharyngeal cancer market?

Answer: The global nasopharyngeal cancer market is expected to grow with a CAGR of 3.4% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the nasopharyngeal cancer market?

Answer: The major drivers for this market are growing incidence of nasopharyngeal cancer and increasing government funding for cancer research and initiatives.

Q3. What are the major segments for nasopharyngeal cancer market?

Answer: The future of the nasopharyngeal cancer market looks promising with opportunities in the hospitals and clinic and ambulatory surgery center markets.

Q4. Who are the key nasopharyngeal cancer market companies?

Answer: Some of the key nasopharyngeal cancer companies are as follows:

  • Biocon
  • Bristol-Myers Squibb Company
  • Cyclacel Pharmaceuticals
  • F. Hoffman-La Roche
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • Theravectys
  • Eli Lilly and Company

Q5. Which nasopharyngeal cancer market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy is expected to witness highest growth over the forecast period as it is considered as very effective treatment for killing cancer cells.

Q6. In nasopharyngeal cancer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of cancer and growing awareness towards treatment and diagnosis in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nasopharyngeal cancer market by therapy (chemotherapy, immunotherapy, radiation therapy, and others), end use (hospitals and clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nasopharyngeal Cancer Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Nasopharyngeal Cancer Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Nasopharyngeal Cancer Market by Therapy
    • 3.3.1: Chemotherapy
    • 3.3.2: Immunotherapy
    • 3.3.3: Radiation Therapy
    • 3.3.4: Others
  • 3.4: Global Nasopharyngeal Cancer Market by End Use
    • 3.4.1: Hospitals and Clinics
    • 3.4.2: Ambulatory Surgery Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Nasopharyngeal Cancer Market by Region
  • 4.2: North American Nasopharyngeal Cancer Market
    • 4.2.2: North American Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
  • 4.3: European Nasopharyngeal Cancer Market
    • 4.3.1: European Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
    • 4.3.2: European Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Nasopharyngeal Cancer Market
    • 4.4.1: APAC Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
    • 4.4.2: APAC Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Nasopharyngeal Cancer Market
    • 4.5.1: ROW Nasopharyngeal Cancer Market by Therapy: Chemotherapy, Immunotherapy, Radiation Therapy, and Others
    • 4.5.2: ROW Nasopharyngeal Cancer Market by End Use: Hospitals and Clinics, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nasopharyngeal Cancer Market by Therapy
    • 6.1.2: Growth Opportunities for the Global Nasopharyngeal Cancer Market by End Use
    • 6.1.3: Growth Opportunities for the Global Nasopharyngeal Cancer Market by Region
  • 6.2: Emerging Trends in the Global Nasopharyngeal Cancer Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nasopharyngeal Cancer Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nasopharyngeal Cancer Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Biocon
  • 7.2: Bristol-Myers Squibb Company
  • 7.3: Cyclacel Pharmaceuticals
  • 7.4: F. Hoffman-La Roche
  • 7.5: Merck & Co
  • 7.6: Novartis
  • 7.7: Pfizer
  • 7.8: Sanofi
  • 7.9: Theravectys
  • 7.10: Eli Lilly and Company